Offer - Urjas Oil for just ₹ 1 X
Ultrabrite is a prescription medicine that is available as a Cream. Secondary and off-label uses of Ultrabrite have also been mentioned below.
The right dosage of Ultrabrite depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Ultrabrite also has some side effects, the most common being Erythema, Skin irritation, Skin Burning. Some other side effects of Ultrabrite have been listed ahead. These side effects of Ultrabrite are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Ultrabrite has a Moderate effect for pregnant women and Severe effect on lactating mothers. It is important to know if Ultrabrite has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ultrabrite related warnings section.
Individuals suffering from medical conditions like Allergy, Eczema must refrain from the use of Ultrabrite since this can cause severe adverse effects. Some other conditions that can be affected by Ultrabrite are listed in the contraindications section below.
Drug reaction of Ultrabrite with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Ultrabrite, it is important to know that it is not safe while driving, and is not habit-forming.
Ultrabrite is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ultrabrite safe for pregnant women?
Ultrabrite has many dangerous side effects in pregnant women. If you are pregnant, do not consume Ultrabrite without medical advice.
Is the use of Ultrabrite safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Ultrabrite. So it is adviced to consult the doctor before using it.
What is the effect of Ultrabrite on the Kidneys?
Ultrabrite is not harmful for kidneys.
What is the effect of Ultrabrite on the Liver?
Ultrabrite does not damage the liver.
What is the effect of Ultrabrite on the Heart?
There are no any side effects of Ultrabrite for the heart.
Ultrabrite should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ultrabrite unless your doctor advises you to do so -
Is this Ultrabrite habit forming or addictive?
No, there is no any evidence that Ultrabrite is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Ultrabrite as it does not make you drowsy.
Is it safe?
Yes, Ultrabrite is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Ultrabrite is not used to treat mental disorders.
Interaction between Food and Ultrabrite
Taking Ultrabrite with food does not cause any problems.
Interaction between Alcohol and Ultrabrite
Information about the interaction of Ultrabrite and alcohol is not currently available because this topic has not been researched yet.
No, Ultrabrite is a prescription drug so do not apply it without consulting a doctor. It can be harmful for the patient to use this medicine without a doctor's recommendation because it can cause very unpleasant side effects. Hence, the patient should seek doctors advice before using this medication by himself or herself.
No, Ultrabrite should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
No, Ultrabrite does not cause hyperpigmentation. It has not been reported by the patients who are taking this drug. In fact, Ultrabrite helps in lightening the area affected by hyperpigmentation (darken spot due to high melanin). However, if you are experiencing hyperpigmentation after taking this drug then it might be due to some other reason. You are advised to discuss it with your doctor.
No, Ultrabrite does not treat the burn. It is used to treat lightening the dark skin. Burning sensation of skin is one of the side effects of this drug. However, if you experience an excessive burning sensation of skin after using this drug then stop using it and inform your doctor immediately without further delay.
Yes, Ultrabrite is safe to use, if it is applied in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed such as sensitive skin, thinning of the skin, redness, irritation, and burning sensation of the skin. Do not hesitate to inform your doctor if you are facing any of the above.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 892
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tri-luma® (fluocinolone acetonide, hydroquinone and tretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 359-360
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Elocon® (mometasone furoate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nasonex® (mometasone furoate monohydrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Asmanex® Twisthaler® (mometasone furoate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A Micro (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renova® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vesanoid® (tretinoin)